Cambridge Biostability Ltd.

Cambridge Biostability has developed the technology to create thermo-stable liquid vaccines, either in single or multivalent forms. Using pioneering, patented methods, vaccines can now be transported anywhere and administered immediately without refrigeration or re-constitution.

This remarkable development is achieved through the production of glass microspheres containing stabilised vaccine. These microspheres float with neutral buoyancy in a liquid which cannot dissolve them but which is harmless upon injection.